Upgrade to SI Premium - Free Trial

Form SCHEDULE 13G/A 60 DEGREES PHARMACEUTICA Filed by: Knight Therapeutics Inc.

May 15, 2026 4:05 PM





Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)




schemaVersion:


SCHEDULE 13G




Comment for Type of Reporting Person: (1) See item 4 below. This constitutes an exit filing for the Reporting Person.


SCHEDULE 13G



Knight Therapeutics Inc.
Signature:/s/ Samira Sakhia
Name/Title:Samira Sakhia
Date:05/15/2026

Categories

SEC Filings